Medico Remedies Limited - Asset Resilience Ratio

Latest as of March 2026: 1.20%

Medico Remedies Limited (MEDICO) has an Asset Resilience Ratio of 1.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medico Remedies Limited (MEDICO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs18.44 Million
≈ $199.45K USD Cash + Short-term Investments

Total Assets

Rs1.53 Billion
≈ $16.59 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2026)

This chart shows how Medico Remedies Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MEDICO asset base.

Liquid Assets Composition Over Time

This chart breaks down Medico Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Medico Remedies Limited carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs18.44 Million 1.2%
Total Liquid Assets Rs18.44 Million 1.20%

Asset Resilience Insights

  • Limited Liquidity: Medico Remedies Limited maintains only 1.20% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Medico Remedies Limited Industry Peers by Asset Resilience Ratio

Compare Medico Remedies Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Medico Remedies Limited (2016–2026)

The table below shows the annual Asset Resilience Ratio data for Medico Remedies Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 1.20% Rs18.44 Million
≈ $199.45K
Rs1.53 Billion
≈ $16.59 Million
-0.01pp
2025-03-31 1.21% Rs14.51 Million
≈ $156.88K
Rs1.20 Billion
≈ $12.96 Million
-0.21pp
2024-03-31 1.42% Rs13.63 Million
≈ $147.41K
Rs961.95 Million
≈ $10.40 Million
-0.03pp
2023-03-31 1.45% Rs12.66 Million
≈ $136.88K
Rs874.48 Million
≈ $9.46 Million
-0.10pp
2022-03-31 1.55% Rs11.79 Million
≈ $127.49K
Rs761.90 Million
≈ $8.24 Million
+0.15pp
2021-03-31 1.40% Rs10.56 Million
≈ $114.18K
Rs756.21 Million
≈ $8.18 Million
+0.39pp
2020-03-31 1.01% Rs7.60 Million
≈ $82.19K
Rs752.69 Million
≈ $8.14 Million
+0.42pp
2019-03-31 0.59% Rs4.50 Million
≈ $48.67K
Rs763.09 Million
≈ $8.25 Million
-0.46pp
2018-03-31 1.05% Rs6.22 Million
≈ $67.29K
Rs593.85 Million
≈ $6.42 Million
+1.02pp
2017-03-31 0.02% Rs120.39K
≈ $1.30K
Rs482.46 Million
≈ $5.22 Million
+0.36pp
2016-03-31 -0.33% Rs-1.52 Million
≈ $-16.39K
Rs455.43 Million
≈ $4.93 Million
--
pp = percentage points

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic
Market Cap
$31.31 Million
Rs2.90 Billion INR
Market Cap Rank
#23717 Global
#1309 in India
Share Price
Rs34.89
Change (1 day)
-3.99%
52-Week Range
Rs32.76 - Rs54.24
All Time High
Rs96.70
About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more